Drug Shortage Report for VENLAFAXINE XR
| Report ID | 236991 | 
| Drug Identification Number | 02354713 | 
| Brand name | VENLAFAXINE XR | 
| Common or Proper name | VENLAFAXINE XR | 
| Company Name | SANIS HEALTH INC | 
| Market Status | MARKETED | 
| Active Ingredient(s) | VENLAFAXINE | 
| Strength(s) | 37.5MG | 
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) | 
| Route of administration | ORAL ORAL | 
| Packaging size | 500 | 
| ATC code | N06AX | 
| ATC description | ANTIDEPRESSANTS | 
| Reason for shortage | Disruption of the manufacture of the drug. | 
| Anticipated start date | 2024-10-11 | 
| Actual start date | 2024-10-04 | 
| Estimated end date | Unknown | 
| Actual end date | 2025-02-10 | 
| Shortage status | Resolved | 
| Updated date | 2025-02-11 | 
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No | 
| Contact Address | 1 PRESIDENTS CHOICE CIRCLE  BRAMPTON, ONTARIO CANADA L6Y 5S5  | 
				
| Company contact information | 
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2025-02-11 | English | Compare | 
| v7 | 2025-02-10 | French | Compare | 
| v6 | 2025-02-10 | English | Compare | 
| v5 | 2024-12-02 | French | Compare | 
| v4 | 2024-12-02 | English | Compare | 
| v3 | 2024-10-12 | English | Compare | 
| v2 | 2024-09-09 | French | Compare | 
| v1 | 2024-09-09 | English | Compare | 
Showing 1 to 8 of 8